The revenues and expenses associated with discontinued operations included in our condensed consolidated statements of operations were as follows: (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Major line items constituting pretax loss of discontinued operations
REVENUE, net	$ 705,143	$ 3,432,436	$ 6,216,826	$ 10,793,269
COST OF GOODS SOLD	(1,882,558)	(2,232,256)	(5,753,658)	(7,029,950)
	(1,177,415)	1,200,180	463,168	3,763,319
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	(2,457,162)	(2,485,272)	(7,055,739)	(7,880,920)
RESEARCH AND DEVELOPMENT	(42,076)	(51,664)	(89,710)	(211,380)
Impairment Expense – Intangible	(3,835,158)		(3,835,158)
Impairment Expense – Goodwill	(868,412)		(868,412)	(3,143,200)
Impairment Expense – Inventory	(837,414)		(837,414)
Impairment Expense – Right of Use Asset	(448,141)		(448,141)
Impairment Expense – Fixed Assets			(9,346)
Loss from Held for Sale Classification	(2,177,844)		(2,177,844)
	(11,843,622)	(1,336,756)	(14,858,596)	(7,472,181)
OTHER INCOME (EXPENSE)
Interest Expense		(44,321)	(70,903)	(114,042)
Interest Income	8,619	21,862	34	28,882
Gain on Sale of Assets to Fagron	4,636,702		4,636,702
Other Income	5,659		26,398
Net Loss from discontinued operations before income taxes	$ (7,192,642)	$ (1,359,215)	$ (10,266,365)	$ (7,557,341)